The burden of gastrointestinal, liver and pancreatic diseases in the US exceeds $135 billion. The overall mission of the Center for Gastrointestinal Biology and Disease (CGIBD) is to promote multidisciplinary research to reduce the burden of digestive diseases. The Center achieves this mission through the following: 1) Core facilities that provide new technologies, expertise, training, technical assistance, laboratory animals, biostatistical and clinical research support. 2) A pilot/feasibility program that provides startup funds to promising investigators. 3) A scientific enrichment program consisting of seminars, special lectures, workshops and competitions for trainees that improve the intellectual climate for gastrointestinal biological research. 4) A professional development and training program that fosters the careers of junior faculty and trainees. Members of the CGIBD are basic and clinical scientists from diverse disciplines dedicated to advancing our understanding of the biology, physiology and epidemiology of digestive diseases. The overarching theme for the Center is Homeostasis, Injury and Repair, a theme that encompasses the wide range of digestive disease research conducted by the membership. Within the theme, members cluster into three areas of research focus: microbiome, clinical/translational research, regenerative medicine/repair. The research base includes 47 full members and 9 associate members from 22 departments. The annual direct costs for digestive disease-related grants to members total $27.9 million. To support the research of members, the Center proposes an Administrative Core to organize the activities of the Center and the following scientific cores: 1) Advanced Analytics; 2) Biostatistics and Clinical Research; 3) Gnotobiotic Animal; 4) Large Animal Models. These cores have evolved to support the scientific directions of center members and to provide new investigative opportunities. The cores improve efficiency, lower cost, and provide services that would not otherwise be available to investigators. Through all of its activities, the Center improves communication, promotes collaboration, develops careers, and generally enriches the environment for digestive disease research.

Public Health Relevance

The annual burden of digestive diseases is considerable, exceeding $135 billion. The Center for Gastrointestinal Biology and Disease promotes multidisciplinary research to improve the understanding of the biology, physiology and epidemiology of digestive diseases. The expectation is that this knowledge will be translated into new strategies for prevention and treatment that will lower the burden of digestive diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034987-35
Application #
9883395
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Perrin, Peter J
Project Start
1996-12-01
Project End
2024-11-30
Budget Start
2019-03-15
Budget End
2020-11-30
Support Year
35
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Koutlas, N T; Eluri, S; Rusin, S et al. (2018) Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis. Dis Esophagus 31:1-7
Reese, Aspen T; Cho, Eugenia H; Klitzman, Bruce et al. (2018) Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. Elife 7:
Walker, Miriam Y; Pratap, Siddharth; Southerland, Janet H et al. (2018) Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 73:81-88
Smid, Marcela C; Ricks, Nitasha M; Panzer, Alexis et al. (2018) Maternal Gut Microbiome Biodiversity in Pregnancy. Am J Perinatol 35:24-30
Keith, Benjamin P; Barrow, Jasmine B; Toyonaga, Takahiko et al. (2018) Colonic epithelial miR-31 associates with the development of Crohn's phenotypes. JCI Insight 3:
Gracz, Adam D; Samsa, Leigh Ann; Fordham, Matthew J et al. (2018) Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates. Gastroenterology 155:1508-1523.e10
Mackie, Duncan I; Al Mutairi, Fuad; Davis, Reema B et al. (2018) hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia. J Exp Med 215:2339-2353
Evon, Donna M; Stewart, Paul W; Amador, Jipcy et al. (2018) A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One 13:e0196908
Smith, Nicholas R; Swain, John R; Davies, Paige S et al. (2018) Monoclonal Antibodies Reveal Dynamic Plasticity Between Lgr5- and Bmi1-Expressing Intestinal Cell Populations. Cell Mol Gastroenterol Hepatol 6:79-96
Efird, William M; Fletcher, Alex G; Draeger, Reid W et al. (2018) Deferoxamine-Soaked Suture Improves Angiogenesis and Repair Potential After Acute Injury of the Chicken Achilles Tendon. Orthop J Sports Med 6:2325967118802792

Showing the most recent 10 out of 944 publications